Koers Panaxia Labs Israel Ltd TEL AVIV STOCK EXCHANGE
Aandelen
PNAX
IL0011043630
Bedrijfsondersteunende diensten
Omzet 2022 | 39,42 mln. 10,37 mln. 9,67 mln. | Omzet 2023 | 19,59 mln. 5,15 mln. 4,81 mln. | Marktkapitalisatie | 22,44 mln. 5,9 mln. 5,51 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -43 mln. -11,31 mln. -10,55 mln. | Nettowinst (verlies) 2023 | -13 mln. -3,42 mln. -3,19 mln. | EV/omzet 2022 | 1,63 x |
Nettoschuld 2022 | 36,12 mln. 9,5 mln. 8,86 mln. | Nettoschuld 2023 | 36,1 mln. 9,5 mln. 8,86 mln. | EV/omzet 2023 | 2,99 x |
K/w-verhouding 2022 |
-0,65
x | K/w-verhouding 2023 |
-168
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 37,69% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Dadi Segal
CEO | Chief Executive Officer | 48 | 01-10-19 |
Assi Rotbart
CHM | Chairman | 49 | 01-10-19 |
Director of Finance/CFO | 66 | 28-12-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Michal Yageel
BRD | Director/Board Member | 53 | 29-12-21 |
Tal Yaron Eldar
BRD | Director/Board Member | 60 | 21-07-16 |
Michal Sapir
BRD | Director/Board Member | 66 | 17-03-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+10,44% | 67,38 mld. | |
+10,60% | 18,09 mld. | |
+10,55% | 13,41 mld. | |
+19,46% | 13,04 mld. | |
+16,53% | 9,92 mld. | |
-33,68% | 5,84 mld. | |
-11,01% | 5,73 mld. | |
-4,05% | 4,93 mld. | |
-4,83% | 4,9 mld. |